The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells

por Kusio-Kobialka, Monika, Podszywalow-Bartnicka, Paulina, Peidis, Philippos, Glodkowska-Mrowka, Eliza, Wolanin, Kamila, Leszak, Grzegorz, Seferynska, Ilona, Stoklosa, Tomasz, Koromilas, Antonis E., Piwocka, Katarzyna
Publicado 2012

FcgRIIIA (CD16)-expressing monocytes mediate the depletion of tumor-infiltrating Tregs via Ipilimumab-dependent ADCC in melanoma patients

por Romano, Emanuela, Kusio-Kobialka, Monika, Foukas, Periklis G, Bichat, Helene, Baumgaertner, Petra, Meyer, Christiane, Ballabeni, Pierluigi, Michielin, Olivier, Weide, Benjamin, Romero, Pedro, Speiser, Daniel E
Publicado 2014

Immunoglobulin expression and the humoral immune response is regulated by the non-canonical poly(A) polymerase TENT5C

por Bilska, Aleksandra, Kusio-Kobiałka, Monika, Krawczyk, Paweł S., Gewartowska, Olga, Tarkowski, Bartosz, Kobyłecki, Kamil, Nowis, Dominika, Golab, Jakub, Gruchota, Jakub, Borsuk, Ewa, Dziembowski, Andrzej, Mroczek, Seweryn
Publicado 2020

The Role of Nibrin in Doxorubicin-Induced Apoptosis and Cell Senescence in Nijmegen Breakage Syndrome Patients Lymphocytes

por Alster, Olga, Bielak-Zmijewska, Anna, Mosieniak, Grazyna, Moreno-Villanueva, Maria, Dudka-Ruszkowska, Wioleta, Wojtala, Aleksandra, Kusio-Kobiałka, Monika, Korwek, Zbigniew, Burkle, Alexander, Piwocka, Katarzyna, Siwicki, Jan K., Sikora, Ewa
Publicado 2014

Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells

por Dudka, Wioleta, Hoser, Grazyna, Mondal, Shamba S., Turos-Korgul, Laura, Swatler, Julian, Kusio-Kobialka, Monika, Wołczyk, Magdalena, Klejman, Agata, Brewinska-Olchowik, Marta, Kominek, Agata, Wiech, Milena, Machnicki, Marcin M., Seferynska, Ilona, Stoklosa, Tomasz, Piwocka, Katarzyna
Publicado 2022

Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma

por Coni, Sonia, Mancuso, Anna Barbara, Di Magno, Laura, Sdruscia, Giulia, Manni, Simona, Serrao, Silvia Maria, Rotili, Dante, Spiombi, Eleonora, Bufalieri, Francesca, Petroni, Marialaura, Kusio-Kobialka, Monika, De Smaele, Enrico, Ferretti, Elisabetta, Capalbo, Carlo, Mai, Antonello, Niewiadomski, Pawel, Screpanti, Isabella, Di Marcotullio, Lucia, Canettieri, Gianluca
Publicado 2017

Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma

por Coni, Sonia, Mancuso, Anna Barbara, Di Magno, Laura, Sdruscia, Giulia, Manni, Simona, Serrao, Silvia Maria, Rotili, Dante, Spiombi, Eleonora, Bufalieri, Francesca, Petroni, Marialaura, Kusio-Kobialka, Monika, De Smaele, Enrico, Ferretti, Elisabetta, Capalbo, Carlo, Mai, Antonello, Niewiadomski, Pawel, Screpanti, Isabella, Di Marcotullio, Lucia, Canettieri, Gianluca
Publicado 2017